In an era of rapid healthcare evolution and ever-changing regulatory landscapes, the role of patient safety groups has transcended traditional pharmacovigilance. This presentation, "Rising to the Challenge of Healthcare’s Evolution and Regulatory Changes: The Device & Digital Chapter," explores the expanded responsibilities of these teams, particularly in addressing the complexities introduced by devices and digital health solutions.
Join us as we delve into the impact on people, processes, and systems, illustrated through a compelling case study of AstraZeneca’s device and digital safety team. Discover how they navigated these challenges to ensure patient safety while fostering innovation in a transformative healthcare environment.
- Looking at how the role of patient safety group has expanded beyond pharmacovigilance.
- Discuss impact on people, process and systems.
- Case study: AstraZeneca’s device & digital safety team
.webp)
